ghk cu im injection GHK-Cu Scalp Solution GHK-Cu Peptide Benefits (And a

As a research compound, AOD9604 UK carries a well-characterised pre-clinical and early-phase clinical research profile developed primarily through the work of Metabolic Pharmaceuticals, with published studies spanning lipid metabolism, adipose biology, 3-adrenergic receptor regulation, cartilage biology, and safety pharmacology

Almost all of GHK-Cus evidence is topical, in-vitro or animal

What You Can Eat and What You Can't You won't be eating much

much lower at community doses Vomiting up to 36% at high doses Diarrhea 23-26% Constipation 17-19% Fatigue 11-13% Pancreatitis risk trials flagged severe abdominal pain for discontinuation and evaluation Gallbladder issues rapid weight loss increases gallstone risk Thyroid C-cell tumors same boxed warning as semaglutide (animal studies) GI side effects were more intense than semaglutide in trial data due to the dual mechanism

Chronic conditions with poor blood supply -- where the tissue needs ongoing support to rebuild vasculature -- fit this profile well